|1||NCT01864746||Active, not recruiting||A Study of Palbociclib in Addition to Standard Endocrine Treatment in Hormone Receptor Positive Her2 Normal Patients With Residual Disease After Neoadjuvant Chemotherapy and Surgery||
||Other / Industry||
||1250||Female||18 Years and older (Adult, Older Adult)||NCT01864746||GBG78/BIG 1-13/NSABP-B-54-I
|PENELOPE-B||November 2013||December 2020||November 2023||May 30, 2013||February 28, 2018||
|2||NCT04031716||Enrolling by invitation||Comprehensive Study of Post-surgical Pain After Pectus or Spine Surgery||
||600||All||8 Years and older (Child, Adult, Older Adult)||NCT04031716||2017-5817||July 6, 2018||June 30, 2023||June 30, 2023||July 24, 2019||July 24, 2019||
† Study has passed its completion date and status has not been verified in more than two years.